カテゴリ： 世界, 医療/バイオ, QYResearch

レボドパ＆ベンセラジド塩酸塩の世界市場2023年：カプセル、錠剤、顆粒

■ 英語タイトル：Global Levodopa and Benserazide Hydrochloride Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8803）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8803
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[レボドパ＆ベンセラジド塩酸塩の世界市場2023年：カプセル、錠剤、顆粒]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はレボドパ＆ベンセラジド塩酸塩のグローバル市場について調査・分析し、世界のレボドパ＆ベンセラジド塩酸塩市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（カプセル、錠剤、顆粒）、用途別セグメント分析（パーキンソン病、症候性パーキンソニズム）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Alfresa Pharma、Devatis、Kyowa Kirin、Neuraxpharm Arzneimittel、Roche Pharma、Taiyo Holdings、Teva Pharmaceutical Industries、Aida Pharmaceutical、Baiyunshan Pharmaceutical、Fuda Pharmaceutical、Xinhua Pharmaceutical、Yishengyuan Pharmaceuticalなどが含まれています。レボドパ＆ベンセラジド塩酸塩のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、レボドパ＆ベンセラジド塩酸塩市場規模を算出する際に考慮しました。

・レボドパ＆ベンセラジド塩酸塩市場の概要
- 製品の定義
- レボドパ＆ベンセラジド塩酸塩の種類別セグメント
- 世界のレボドパ＆ベンセラジド塩酸塩市場規模：タイプ別分析（カプセル、錠剤、顆粒）
- レボドパ＆ベンセラジド塩酸塩の用途別セグメント
- 世界のレボドパ＆ベンセラジド塩酸塩市場規模：用途別分析（パーキンソン病、症候性パーキンソニズム）
- 世界のレボドパ＆ベンセラジド塩酸塩市場規模予測（2018年-2029年）
- レボドパ＆ベンセラジド塩酸塩の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- レボドパ＆ベンセラジド塩酸塩市場の競争状況およびトレンド

・レボドパ＆ベンセラジド塩酸塩の地域別市場規模
- 北米のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 米国のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- ヨーロッパのレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- アジア太平洋のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 中国のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 日本のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 韓国のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- インドのレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- オーストラリアのレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 中南米のレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）
- 中東・アフリカのレボドパ＆ベンセラジド塩酸塩市場規模（2018年-2029年）

・種類別セグメント：カプセル、錠剤、顆粒
- 世界のレボドパ＆ベンセラジド塩酸塩のタイプ別販売量（2018年-2023年）
- 世界のレボドパ＆ベンセラジド塩酸塩のタイプ別売上（2018年-2023年）
- 世界のレボドパ＆ベンセラジド塩酸塩のタイプ別価格

・用途別セグメント：パーキンソン病、症候性パーキンソニズム
- 世界のレボドパ＆ベンセラジド塩酸塩の用途別販売量（2018年-2023年）
- 世界のレボドパ＆ベンセラジド塩酸塩の用途別売上（2018年-2023年）
- 世界のレボドパ＆ベンセラジド塩酸塩の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Alfresa Pharma、Devatis、Kyowa Kirin、Neuraxpharm Arzneimittel、Roche Pharma、Taiyo Holdings、Teva Pharmaceutical Industries、Aida Pharmaceutical、Baiyunshan Pharmaceutical、Fuda Pharmaceutical、Xinhua Pharmaceutical、Yishengyuan Pharmaceutical

・産業チェーンと販売チャネルの分析
- レボドパ＆ベンセラジド塩酸塩産業チェーン分析
- レボドパ＆ベンセラジド塩酸塩の主要原材料
- レボドパ＆ベンセラジド塩酸塩の販売チャネル
- レボドパ＆ベンセラジド塩酸塩のディストリビューター
- レボドパ＆ベンセラジド塩酸塩の主要顧客

・レボドパ＆ベンセラジド塩酸塩市場ダイナミクス
- レボドパ＆ベンセラジド塩酸塩の業界動向
- レボドパ＆ベンセラジド塩酸塩市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Levodopa and Benserazide Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Levodopa and Benserazide Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Levodopa and Benserazide Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Levodopa and Benserazide Hydrochloride include Alfresa Pharma, Devatis, Kyowa Kirin, Neuraxpharm Arzneimittel, Roche Pharma, Taiyo Holdings, Teva Pharmaceutical Industries, Aida Pharmaceutical and Baiyunshan Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Levodopa and Benserazide Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levodopa and Benserazide Hydrochloride.
The Levodopa and Benserazide Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Levodopa and Benserazide Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levodopa and Benserazide Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Alfresa Pharma
Devatis
Kyowa Kirin
Neuraxpharm Arzneimittel
Roche Pharma
Taiyo Holdings
Teva Pharmaceutical Industries
Aida Pharmaceutical
Baiyunshan Pharmaceutical
Fuda Pharmaceutical
Xinhua Pharmaceutical
Yishengyuan Pharmaceutical
Segment by Type
Capsules
Tablets
Granules
Segment by Application
Parkinson’s Disease
Symptomatic Parkinsonism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Levodopa and Benserazide Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Levodopa and Benserazide Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Levodopa and Benserazide Hydrochloride Market Overview
1.1 Product Overview and Scope of Levodopa and Benserazide Hydrochloride
1.2 Levodopa and Benserazide Hydrochloride Segment by Type
1.2.1 Global Levodopa and Benserazide Hydrochloride Market Value Comparison by Type (2023-2029)
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Granules
1.3 Levodopa and Benserazide Hydrochloride Segment by Application
1.3.1 Global Levodopa and Benserazide Hydrochloride Market Value by Application: (2023-2029)
1.3.2 Parkinson’s Disease
1.3.3 Symptomatic Parkinsonism
1.4 Global Levodopa and Benserazide Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Levodopa and Benserazide Hydrochloride Revenue 2018-2029
1.4.2 Global Levodopa and Benserazide Hydrochloride Sales 2018-2029
1.4.3 Global Levodopa and Benserazide Hydrochloride Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Levodopa and Benserazide Hydrochloride Market Competition by Manufacturers
2.1 Global Levodopa and Benserazide Hydrochloride Sales Market Share by Manufacturers (2018-2023)
2.2 Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Levodopa and Benserazide Hydrochloride Average Price by Manufacturers (2018-2023)
2.4 Global Levodopa and Benserazide Hydrochloride Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Levodopa and Benserazide Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Levodopa and Benserazide Hydrochloride, Product Type & Application
2.7 Levodopa and Benserazide Hydrochloride Market Competitive Situation and Trends
2.7.1 Levodopa and Benserazide Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Levodopa and Benserazide Hydrochloride Players Market Share by Revenue
2.7.3 Global Levodopa and Benserazide Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Levodopa and Benserazide Hydrochloride Retrospective Market Scenario by Region
3.1 Global Levodopa and Benserazide Hydrochloride Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Levodopa and Benserazide Hydrochloride Global Levodopa and Benserazide Hydrochloride Sales by Region: 2018-2029
3.2.1 Global Levodopa and Benserazide Hydrochloride Sales by Region: 2018-2023
3.2.2 Global Levodopa and Benserazide Hydrochloride Sales by Region: 2024-2029
3.3 Global Levodopa and Benserazide Hydrochloride Global Levodopa and Benserazide Hydrochloride Revenue by Region: 2018-2029
3.3.1 Global Levodopa and Benserazide Hydrochloride Revenue by Region: 2018-2023
3.3.2 Global Levodopa and Benserazide Hydrochloride Revenue by Region: 2024-2029
3.4 North America Levodopa and Benserazide Hydrochloride Market Facts & Figures by Country
3.4.1 North America Levodopa and Benserazide Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Levodopa and Benserazide Hydrochloride Sales by Country (2018-2029)
3.4.3 North America Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Levodopa and Benserazide Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Levodopa and Benserazide Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Levodopa and Benserazide Hydrochloride Sales by Country (2018-2029)
3.5.3 Europe Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Levodopa and Benserazide Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Levodopa and Benserazide Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Levodopa and Benserazide Hydrochloride Sales by Country (2018-2029)
3.6.3 Asia Pacific Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Levodopa and Benserazide Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Levodopa and Benserazide Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Levodopa and Benserazide Hydrochloride Sales by Country (2018-2029)
3.7.3 Latin America Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Levodopa and Benserazide Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Levodopa and Benserazide Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Levodopa and Benserazide Hydrochloride Sales by Country (2018-2029)
3.8.3 Middle East and Africa Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Levodopa and Benserazide Hydrochloride Sales by Type (2018-2029)
4.1.1 Global Levodopa and Benserazide Hydrochloride Sales by Type (2018-2023)
4.1.2 Global Levodopa and Benserazide Hydrochloride Sales by Type (2024-2029)
4.1.3 Global Levodopa and Benserazide Hydrochloride Sales Market Share by Type (2018-2029)
4.2 Global Levodopa and Benserazide Hydrochloride Revenue by Type (2018-2029)
4.2.1 Global Levodopa and Benserazide Hydrochloride Revenue by Type (2018-2023)
4.2.2 Global Levodopa and Benserazide Hydrochloride Revenue by Type (2024-2029)
4.2.3 Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Type (2018-2029)
4.3 Global Levodopa and Benserazide Hydrochloride Price by Type (2018-2029)
5 Segment by Application
5.1 Global Levodopa and Benserazide Hydrochloride Sales by Application (2018-2029)
5.1.1 Global Levodopa and Benserazide Hydrochloride Sales by Application (2018-2023)
5.1.2 Global Levodopa and Benserazide Hydrochloride Sales by Application (2024-2029)
5.1.3 Global Levodopa and Benserazide Hydrochloride Sales Market Share by Application (2018-2029)
5.2 Global Levodopa and Benserazide Hydrochloride Revenue by Application (2018-2029)
5.2.1 Global Levodopa and Benserazide Hydrochloride Revenue by Application (2018-2023)
5.2.2 Global Levodopa and Benserazide Hydrochloride Revenue by Application (2024-2029)
5.2.3 Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Application (2018-2029)
5.3 Global Levodopa and Benserazide Hydrochloride Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alfresa Pharma
6.1.1 Alfresa Pharma Corporation Information
6.1.2 Alfresa Pharma Description and Business Overview
6.1.3 Alfresa Pharma Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alfresa Pharma Levodopa and Benserazide Hydrochloride Product Portfolio
6.1.5 Alfresa Pharma Recent Developments/Updates
6.2 Devatis
6.2.1 Devatis Corporation Information
6.2.2 Devatis Description and Business Overview
6.2.3 Devatis Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Devatis Levodopa and Benserazide Hydrochloride Product Portfolio
6.2.5 Devatis Recent Developments/Updates
6.3 Kyowa Kirin
6.3.1 Kyowa Kirin Corporation Information
6.3.2 Kyowa Kirin Description and Business Overview
6.3.3 Kyowa Kirin Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Kyowa Kirin Levodopa and Benserazide Hydrochloride Product Portfolio
6.3.5 Kyowa Kirin Recent Developments/Updates
6.4 Neuraxpharm Arzneimittel
6.4.1 Neuraxpharm Arzneimittel Corporation Information
6.4.2 Neuraxpharm Arzneimittel Description and Business Overview
6.4.3 Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Product Portfolio
6.4.5 Neuraxpharm Arzneimittel Recent Developments/Updates
6.5 Roche Pharma
6.5.1 Roche Pharma Corporation Information
6.5.2 Roche Pharma Description and Business Overview
6.5.3 Roche Pharma Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Pharma Levodopa and Benserazide Hydrochloride Product Portfolio
6.5.5 Roche Pharma Recent Developments/Updates
6.6 Taiyo Holdings
6.6.1 Taiyo Holdings Corporation Information
6.6.2 Taiyo Holdings Description and Business Overview
6.6.3 Taiyo Holdings Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Taiyo Holdings Levodopa and Benserazide Hydrochloride Product Portfolio
6.6.5 Taiyo Holdings Recent Developments/Updates
6.7 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Product Portfolio
6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.8 Aida Pharmaceutical
6.8.1 Aida Pharmaceutical Corporation Information
6.8.2 Aida Pharmaceutical Description and Business Overview
6.8.3 Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Product Portfolio
6.8.5 Aida Pharmaceutical Recent Developments/Updates
6.9 Baiyunshan Pharmaceutical
6.9.1 Baiyunshan Pharmaceutical Corporation Information
6.9.2 Baiyunshan Pharmaceutical Description and Business Overview
6.9.3 Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Product Portfolio
6.9.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.10 Fuda Pharmaceutical
6.10.1 Fuda Pharmaceutical Corporation Information
6.10.2 Fuda Pharmaceutical Description and Business Overview
6.10.3 Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Product Portfolio
6.10.5 Fuda Pharmaceutical Recent Developments/Updates
6.11 Xinhua Pharmaceutical
6.11.1 Xinhua Pharmaceutical Corporation Information
6.11.2 Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Description and Business Overview
6.11.3 Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Product Portfolio
6.11.5 Xinhua Pharmaceutical Recent Developments/Updates
6.12 Yishengyuan Pharmaceutical
6.12.1 Yishengyuan Pharmaceutical Corporation Information
6.12.2 Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Description and Business Overview
6.12.3 Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Product Portfolio
6.12.5 Yishengyuan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Levodopa and Benserazide Hydrochloride Industry Chain Analysis
7.2 Levodopa and Benserazide Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Levodopa and Benserazide Hydrochloride Production Mode & Process
7.4 Levodopa and Benserazide Hydrochloride Sales and Marketing
7.4.1 Levodopa and Benserazide Hydrochloride Sales Channels
7.4.2 Levodopa and Benserazide Hydrochloride Distributors
7.5 Levodopa and Benserazide Hydrochloride Customers
8 Levodopa and Benserazide Hydrochloride Market Dynamics
8.1 Levodopa and Benserazide Hydrochloride Industry Trends
8.2 Levodopa and Benserazide Hydrochloride Market Drivers
8.3 Levodopa and Benserazide Hydrochloride Market Challenges
8.4 Levodopa and Benserazide Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Levodopa and Benserazide Hydrochloride Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Levodopa and Benserazide Hydrochloride Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Levodopa and Benserazide Hydrochloride Market Competitive Situation by Manufacturers in 2022
Table 4. Global Levodopa and Benserazide Hydrochloride Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Levodopa and Benserazide Hydrochloride Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Levodopa and Benserazide Hydrochloride Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Levodopa and Benserazide Hydrochloride Average Price (US$/g) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Levodopa and Benserazide Hydrochloride, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Levodopa and Benserazide Hydrochloride, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Levodopa and Benserazide Hydrochloride, Product Type & Application
Table 12. Global Key Manufacturers of Levodopa and Benserazide Hydrochloride, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Levodopa and Benserazide Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Levodopa and Benserazide Hydrochloride as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Levodopa and Benserazide Hydrochloride Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Levodopa and Benserazide Hydrochloride Sales by Region (2018-2023) & (Kg)
Table 18. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Region (2018-2023)
Table 19. Global Levodopa and Benserazide Hydrochloride Sales by Region (2024-2029) & (Kg)
Table 20. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Region (2024-2029)
Table 21. Global Levodopa and Benserazide Hydrochloride Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Region (2018-2023)
Table 23. Global Levodopa and Benserazide Hydrochloride Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Region (2024-2029)
Table 25. North America Levodopa and Benserazide Hydrochloride Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Levodopa and Benserazide Hydrochloride Sales by Country (2018-2023) & (Kg)
Table 27. North America Levodopa and Benserazide Hydrochloride Sales by Country (2024-2029) & (Kg)
Table 28. North America Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Levodopa and Benserazide Hydrochloride Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Levodopa and Benserazide Hydrochloride Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Levodopa and Benserazide Hydrochloride Sales by Country (2018-2023) & (Kg)
Table 32. Europe Levodopa and Benserazide Hydrochloride Sales by Country (2024-2029) & (Kg)
Table 33. Europe Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Levodopa and Benserazide Hydrochloride Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Levodopa and Benserazide Hydrochloride Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Levodopa and Benserazide Hydrochloride Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Levodopa and Benserazide Hydrochloride Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Levodopa and Benserazide Hydrochloride Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Levodopa and Benserazide Hydrochloride Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Levodopa and Benserazide Hydrochloride Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Levodopa and Benserazide Hydrochloride Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Levodopa and Benserazide Hydrochloride Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Levodopa and Benserazide Hydrochloride Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Levodopa and Benserazide Hydrochloride Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Levodopa and Benserazide Hydrochloride Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Levodopa and Benserazide Hydrochloride Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Levodopa and Benserazide Hydrochloride Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Levodopa and Benserazide Hydrochloride Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Levodopa and Benserazide Hydrochloride Sales (Kg) by Type (2018-2023)
Table 51. Global Levodopa and Benserazide Hydrochloride Sales (Kg) by Type (2024-2029)
Table 52. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Type (2018-2023)
Table 53. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Type (2024-2029)
Table 54. Global Levodopa and Benserazide Hydrochloride Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Levodopa and Benserazide Hydrochloride Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Type (2018-2023)
Table 57. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Type (2024-2029)
Table 58. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Type (2018-2023)
Table 59. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Type (2024-2029)
Table 60. Global Levodopa and Benserazide Hydrochloride Sales (Kg) by Application (2018-2023)
Table 61. Global Levodopa and Benserazide Hydrochloride Sales (Kg) by Application (2024-2029)
Table 62. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Application (2018-2023)
Table 63. Global Levodopa and Benserazide Hydrochloride Sales Market Share by Application (2024-2029)
Table 64. Global Levodopa and Benserazide Hydrochloride Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Levodopa and Benserazide Hydrochloride Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Application (2018-2023)
Table 67. Global Levodopa and Benserazide Hydrochloride Revenue Market Share by Application (2024-2029)
Table 68. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Application (2018-2023)
Table 69. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Application (2024-2029)
Table 70. Alfresa Pharma Corporation Information
Table 71. Alfresa Pharma Description and Business Overview
Table 72. Alfresa Pharma Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 73. Alfresa Pharma Levodopa and Benserazide Hydrochloride Product
Table 74. Alfresa Pharma Recent Developments/Updates
Table 75. Devatis Corporation Information
Table 76. Devatis Description and Business Overview
Table 77. Devatis Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 78. Devatis Levodopa and Benserazide Hydrochloride Product
Table 79. Devatis Recent Developments/Updates
Table 80. Kyowa Kirin Corporation Information
Table 81. Kyowa Kirin Description and Business Overview
Table 82. Kyowa Kirin Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 83. Kyowa Kirin Levodopa and Benserazide Hydrochloride Product
Table 84. Kyowa Kirin Recent Developments/Updates
Table 85. Neuraxpharm Arzneimittel Corporation Information
Table 86. Neuraxpharm Arzneimittel Description and Business Overview
Table 87. Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 88. Neuraxpharm Arzneimittel Levodopa and Benserazide Hydrochloride Product
Table 89. Neuraxpharm Arzneimittel Recent Developments/Updates
Table 90. Roche Pharma Corporation Information
Table 91. Roche Pharma Description and Business Overview
Table 92. Roche Pharma Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 93. Roche Pharma Levodopa and Benserazide Hydrochloride Product
Table 94. Roche Pharma Recent Developments/Updates
Table 95. Taiyo Holdings Corporation Information
Table 96. Taiyo Holdings Description and Business Overview
Table 97. Taiyo Holdings Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 98. Taiyo Holdings Levodopa and Benserazide Hydrochloride Product
Table 99. Taiyo Holdings Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Corporation Information
Table 101. Teva Pharmaceutical Industries Description and Business Overview
Table 102. Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 103. Teva Pharmaceutical Industries Levodopa and Benserazide Hydrochloride Product
Table 104. Teva Pharmaceutical Industries Recent Developments/Updates
Table 105. Aida Pharmaceutical Corporation Information
Table 106. Aida Pharmaceutical Description and Business Overview
Table 107. Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 108. Aida Pharmaceutical Levodopa and Benserazide Hydrochloride Product
Table 109. Aida Pharmaceutical Recent Developments/Updates
Table 110. Baiyunshan Pharmaceutical Corporation Information
Table 111. Baiyunshan Pharmaceutical Description and Business Overview
Table 112. Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 113. Baiyunshan Pharmaceutical Levodopa and Benserazide Hydrochloride Product
Table 114. Baiyunshan Pharmaceutical Recent Developments/Updates
Table 115. Fuda Pharmaceutical Corporation Information
Table 116. Fuda Pharmaceutical Description and Business Overview
Table 117. Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 118. Fuda Pharmaceutical Levodopa and Benserazide Hydrochloride Product
Table 119. Fuda Pharmaceutical Recent Developments/Updates
Table 120. Xinhua Pharmaceutical Corporation Information
Table 121. Xinhua Pharmaceutical Description and Business Overview
Table 122. Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 123. Xinhua Pharmaceutical Levodopa and Benserazide Hydrochloride Product
Table 124. Xinhua Pharmaceutical Recent Developments/Updates
Table 125. Yishengyuan Pharmaceutical Corporation Information
Table 126. Yishengyuan Pharmaceutical Description and Business Overview
Table 127. Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 128. Yishengyuan Pharmaceutical Levodopa and Benserazide Hydrochloride Product
Table 129. Yishengyuan Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Levodopa and Benserazide Hydrochloride Distributors List
Table 133. Levodopa and Benserazide Hydrochloride Customers List
Table 134. Levodopa and Benserazide Hydrochloride Market Trends
Table 135. Levodopa and Benserazide Hydrochloride Market Drivers
Table 136. Levodopa and Benserazide Hydrochloride Market Challenges
Table 137. Levodopa and Benserazide Hydrochloride Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Levodopa and Benserazide Hydrochloride
Figure 2. Global Levodopa and Benserazide Hydrochloride Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Levodopa and Benserazide Hydrochloride Market Share by Type in 2022 & 2029
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Granules Product Picture
Figure 7. Global Levodopa and Benserazide Hydrochloride Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Levodopa and Benserazide Hydrochloride Market Share by Application in 2022 & 2029
Figure 9. Parkinson's Disease
Figure 10. Symptomatic Parkinsonism
Figure 11. Global Levodopa and Benserazide Hydrochloride Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Levodopa and Benserazide Hydrochloride Market Size (2018-2029) & (US$ Million)
Figure 13. Global Levodopa and Benserazide Hydrochloride Sales (2018-2029) & (Kg)
Figure 14. Global Levodopa and Benserazide Hydrochloride Average Price (US$/g) & (2018-2029)
Figure 15. Levodopa and Benserazide Hydrochloride Report Years Considered
Figure 16. Levodopa and Benserazide Hydrochloride Sales Share by Manufacturers in 2022
Figure 17. Global Levodopa and Benserazide Hydrochloride Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Levodopa and Benserazide Hydrochloride Players: Market Share by Revenue in 2022
Figure 19. Levodopa and Benserazide Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Levodopa and Benserazide Hydrochloride Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Levodopa and Benserazide Hydrochloride Sales Market Share by Country (2018-2029)
Figure 22. North America Levodopa and Benserazide Hydrochloride Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Levodopa and Benserazide Hydrochloride Sales Market Share by Country (2018-2029)
Figure 26. Europe Levodopa and Benserazide Hydrochloride Revenue Market Share by Country (2018-2029)
Figure 27. Germany Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Levodopa and Benserazide Hydrochloride Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Levodopa and Benserazide Hydrochloride Revenue Market Share by Region (2018-2029)
Figure 34. China Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Levodopa and Benserazide Hydrochloride Sales Market Share by Country (2018-2029)
Figure 45. Latin America Levodopa and Benserazide Hydrochloride Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Levodopa and Benserazide Hydrochloride Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Levodopa and Benserazide Hydrochloride Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Levodopa and Benserazide Hydrochloride Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Levodopa and Benserazide Hydrochloride by Type (2018-2029)
Figure 55. Global Revenue Market Share of Levodopa and Benserazide Hydrochloride by Type (2018-2029)
Figure 56. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Type (2018-2029)
Figure 57. Global Sales Market Share of Levodopa and Benserazide Hydrochloride by Application (2018-2029)
Figure 58. Global Revenue Market Share of Levodopa and Benserazide Hydrochloride by Application (2018-2029)
Figure 59. Global Levodopa and Benserazide Hydrochloride Price (US$/g) by Application (2018-2029)
Figure 60. Levodopa and Benserazide Hydrochloride Value Chain
Figure 61. Levodopa and Benserazide Hydrochloride Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 關心蘇河膠廠のグローバル市場展望 2023年-2029年：0.35g/カプセル、0.25g/カプセル
  • 経口メサラジンの世界市場2023年：錠剤、カプセル、顆粒
  • ラベプラゾールのグローバル市場展望 2023年-2029年：タブレット、カプセル
  • アカルボース医薬品の世界市場2023年：錠剤、カプセル
  • ペニシリンVカリウムのグローバル市場展望 2023年-2029年：錠剤、カプセル、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8803 )"レボドパ＆ベンセラジド塩酸塩の世界市場2023年：カプセル、錠剤、顆粒" (英文：Global Levodopa and Benserazide Hydrochloride Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。